JP Morgan Maintains Neutral on LifeStance Health Gr, Raises Price Target to $9
Benzinga Newsdesk 5 months ago
NewsPrice TargetAnalyst Ratings
JP Morgan analyst Lisa Gill maintains LifeStance Health Gr (NASDAQ:LFST) with a Neutral and raises the price target from $8 to $9.
JP Morgan analyst Lisa Gill maintains LifeStance Health Gr (NASDAQ:LFST) with a Neutral and raises the price target from $8 to $9.